Lawyers

Partners

Priscilla
van den Perre

"Priscilla Van Den Perre is an excellent tax adviser who provides highly relevant advice, has great and swift judgement, and is very commercial" LEGAL 500 EMEA 2020

Send a message

* Mandatory fields

Priscilla van den Perre specializes in corporate tax and is regularly involved in corporate transactions, in particular LBOs and restructuring projects. She is also regularly involved in the M&A transactions and has an expertise in the setting-up of investment vehicles (private equity, debt and real estate funds).

Member of the Paris Bar since 2005, she holds an advanced degree (DESS) in Business and Tax law from the University of Paris I (Panthéon Sorbonne) (2002).

She joined De Pardieu Brocas Maffei in June 2017 as Counsel and she was co-opted as Partner in 2019. Priscilla started her career in 2005 at Ashurst, where she became Counsel in 2014.

Press releases

Advising Société Générale Capital Partenaires on the acquisition of a minority stake in the Mesotrans group

De Pardieu Brocas Maffei has advised Société Générale Capital Partenaires on the acquisition of a minority stake, alongside Bpifrance, in the Mesotrans group, a key player in the French market [...]

Advising Siparex on the acquisition of 90% of the share capital of the French medical equipment group Winncare

Advising Siparex on the acquisition of 90% of the share capital of the French medical equipment group Winncare, from IDI, alongside Capza with the subcription of a mezzanine [...]

Advising the shareholders sellers (21 INVEST, les fondateurs, Amundi PE Funds, Swen Capital Partners) on the sale of their majority share on the capital of DL Software to TA Associates

Advising the shareholders sellers (21 INVEST, les fondateurs, Amundi PE Funds, Swen Capital Partners) on the sale of their majority share on the capital of DL Software, a leading France-based group [...]

Advising ProductLige Group and its majority shareholder 21 invest on the acquisition from Galiena Capital of AxPharma group

Advising ProductLige Group and its majority shareholder 21 invest on the acquisition from Galiena Capital of AxPharma group, a prominent pharmacovigilance service provider in Europe. The group [...]